Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44329 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL789865 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL18875934 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1038060 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL538822 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7033108 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8934997 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3095679 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4432484 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3675109 | 1.00 | DNM1 (0.52) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290981-A | Putty for light alloy and preparation method thereof | 广州市中瀚创能新材料科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4748832-A2 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2026-05-27 | — | — | EP | disclosed |
| EP-4031522-B1 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2026-04-22 | — | — | EP | disclosed |
| US-12559450-B2 | Lipidoids for nucleic acid transfection and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2026-02-24 | — | — | US | disclosed |
| US-20240336558-A1 | IONIZABLE LIPID BASED ON ENDOGENOUS DICARBOXYLIC ACID AS WELL AS PREPARATION METHOD AND USE THEREOF | SHANDONG UNIVERSITY (CN) | 2024-10-10 | — | — | US | disclosed |
| CN-118290981-A | Putty for light alloy and preparation method thereof | 广州市中瀚创能新材料科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-116283667-B | Functional isocyanate crosslinking agent and preparation method thereof | 江苏海洋大学 | 2023-12-29 | — | — | CN | disclosed |
| CN-116283674-B | Isocyanate crosslinking agent containing disulfo betaine and preparation method thereof | 江苏海洋大学 | 2023-11-24 | — | — | CN | disclosed |
| US-20230265049-A1 | Lipidoids for Nucleic Acid Transfection and Use Thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2023-08-24 | — | — | US | disclosed |
| CN-116550161-A | Application of multifunctional isocyanate crosslinking agent in surface modification of aromatic polyamide composite membrane | 江苏海洋大学 | 2023-08-08 | — | — | CN | disclosed |
| US-20180194798-A1 | PROGESTERONE-CATIONIC LIPID HYBRID AS ANTICANCER AGENT AND THE PROCESS OF SYNTHESIS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-07-12 | — | — | US | disclosed |
| EP-3275888-A1 | PROGESTERONE-CATIONIC LIPID HYBRID AS ANTICANCER AGENT AND THE PROCESS OF SYNTHESIS THEREOF | Council of Scientific & Industrial Research (IN) | 2018-01-31 | — | — | EP | disclosed |
| CN-103406065-B | Novel amido-linkage imidazolium salt gemini surfactant and preparation method thereof | UNIV QIQIHAR | 2015-04-15 | — | — | CN | disclosed |
| CN-103406065-A | Novel amido-linkage imidazolium salt gemini surfactant and preparation method thereof | UNIV QIQIHAR | 2013-11-27 | — | — | CN | disclosed |
| EP-0824576-B1 | MULTILAYER SECOND-ORDER NONLINEAR OPTICAL FILMS OF HEAD-TO-HEAD MAINCHAIN CHROMOPHORIC POLYMERS | US NAVY (US) | 2000-12-13 | — | — | EP | disclosed |
| EP-0824576-A4 | MULTILAYER SECOND-ORDER NONLINEAR OPTICAL FILMS OF HEAD-TO-HEAD MAINCHAIN CHROMOPHORIC POLYMERS | US NAVY (US) | 1998-04-15 | — | — | EP | disclosed |
| EP-0824576-A1 | MULTILAYER SECOND-ORDER NONLINEAR OPTICAL FILMS OF HEAD-TO-HEAD MAINCHAIN CHROMOPHORIC POLYMERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE NAVY (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034928-A1 | MULTILAYER SECOND-ORDER NONLINEAR OPTICAL FILMS OF HEAD-TO-HEAD MAINCHAIN CHROMOPHORIC POLYMERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-11-07 | — | — | WO | disclosed |
| US-5115009-A | Thermoplastic resins used in food and beverage containers | SHELL OIL COMPANY (US) | 1992-05-19 | — | — | US | disclosed |
| US-3999942-A | N-Acyloyl-N-alkyl-alkylenediamines as dye levelers | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265049-A1 | Lipidoids for Nucleic Acid Transfection and Use Thereof | NPC1L1, CETP, NR1H2 | DNM1 1584/4885TSHR 1316/4885MEN1 2470/4885 |
| US-12559450-B2 | Lipidoids for nucleic acid transfection and use thereof | NPC1, NSUN3, NSUN2 | DNM1 1276/4885TSHR 1218/4885MEN1 1839/4885 |
| US-20180194798-A1 | PROGESTERONE-CATIONIC LIPID HYBRID AS ANTICANCER AGENT AND THE PROCESS OF SYNTHESIS THEREOF | PGR, PGRMC2, PGRMC1 | DNM1 2575/4885TSHR 443/4885MEN1 1788/4885 |
| US-20240336558-A1 | IONIZABLE LIPID BASED ON ENDOGENOUS DICARBOXYLIC ACID AS WELL AS PREPARATION METHOD AND USE THEREOF | ACADM, SLC27A1, SLC27A2 | DNM1 818/4885TSHR 3319/4885MEN1 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.